Observed‐to‐expected incidence ratios of second malignant neoplasms after radiation therapy for medulloblastoma: A Surveillance, Epidemiology, and End Results analysis

The authors analyzed the incidence and types of second malignant neoplasms (SMNs) in patients treated for medulloblastoma.

[1]  S. Khatua,et al.  Development of second primary tumors and outcomes in medulloblastoma by treatment modality: A Surveillance, Epidemiology, and End Results analysis , 2020, Pediatric blood & cancer.

[2]  Jian Cheng,et al.  The evolution of proton beam therapy: Current and future status. , 2017, Molecular and clinical oncology.

[3]  T. Zhou,et al.  High-risk medulloblastoma: a pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031). , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  R K Sachs,et al.  Radiation-induced cancer: a modern view. , 2012, The British journal of radiology.

[5]  Yukiko Shimizu,et al.  Studies of the Mortality of Atomic Bomb Survivors.Report 12, Part I. Cancer: 1950–1990 , 2012, Radiation research.

[6]  Yukiko Shimizu,et al.  Studies of the Mortality of Atomic Bomb Survivors, Report 14, 1950–2003: An Overview of Cancer and Noncancer Diseases , 2012, Radiation research.

[7]  D. Brenner,et al.  Cancer risks after radiation exposure in middle age. , 2010, Journal of the National Cancer Institute.

[8]  Simon Bouffler,et al.  Assessing cancer risks of low-dose radiation , 2009, Nature Reviews Cancer.

[9]  F. Berthold,et al.  Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy. , 2009, Neuro-oncology.

[10]  Roberto Orecchia,et al.  Pediatric medulloblastoma: toxicity of current treatment and potential role of protontherapy. , 2009, Cancer treatment reviews.

[11]  P. Duffner.  The long term effects of chemotherapy on the central nervous system , 2006, Journal of biology.

[12]  Mark Noble,et al.  CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo , 2006, Journal of biology.

[13]  H. Kooy,et al.  Proton beam therapy , 2005, British Journal of Cancer.

[14]  A. Paulino,et al.  SECONDARY NEOPLASMS AFTER RADIOTHERAPY FOR A CHILDHOOD SOLID TUMOR , 2005, Pediatric hematology and oncology.

[15]  C. Dang,et al.  Histopathological and Molecular Prognostic Markers in Medulloblastoma: c‐myc, N‐myc, TrkC, and Anaplasia , 2004, Journal of neuropathology and experimental neurology.

[16]  M. Souweidane,et al.  Patterns of failure using a conformal radiation therapy tumor bed boost for medulloblastoma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  J. Grill,et al.  Patterns of neuropsychological deficits in children with medulloblastoma according to craniospatial irradiation doses , 2000, Developmental medicine and child neurology.

[18]  L. Rorke,et al.  Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  L. Rorke,et al.  Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  M. Tucker,et al.  Second cancers after medulloblastoma: population-based results from the United States and Sweden , 1997, Cancer Causes & Control.

[21]  M. Loda,et al.  Large‐Cell Medulloblastomas: A Distinct Variant with Highly Aggressive Behavior , 1992, The American journal of surgical pathology.

[22]  W. Wara,et al.  The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. , 1990, Journal of neurosurgery.

[23]  H. Bloom,et al.  Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). , 1990, European journal of cancer.

[24]  K. Winston,et al.  Pre-radiation chemotherapy for infants and poor prognosis children with medulloblastoma. , 1988, International journal of radiation oncology, biology, physics.

[25]  P. Suresh,et al.  Medulloblastoma: A common pediatric tumor: Prognostic factors and predictors of outcome , 2015, Asian journal of neurosurgery.

[26]  T. Zhou,et al.  Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961. , 2013, Neuro-oncology.

[27]  A. Niemierko,et al.  Secondary Carcinogenesis in Patients Treated with Radiation: A Review of Data on Radiation-Induced Cancers in Human, Non-human Primate, Canine and Rodent Subjects , 2007, Radiation research.

[28]  T. Morioka,et al.  Radiation-Induced Brain Tumours: Potential Late Complications of Radiation Therapy for Brain Tumours , 1998, Acta Neurochirurgica.

[29]  J. Kaldor,et al.  Secondary malignancies following cancer chemotherapy. , 1994, Acta oncologica.

[30]  R. Fry,et al.  External radiation carcinogenesis , 1987 .